Skip to content

Dry Needling vs. Cupping Therapy in MPS

Comparison of the Effectiveness of Dry Needling and Cupping Therapy in Patients With Myofascial Pain Syndrome: A Randomized Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07688317
Enrollment
92
Registered
2026-07-07
Start date
2022-03-15
Completion date
2025-08-29
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome (MPS)

Keywords

Myofascial pain syndrome, Trigger point, Dry needling, Dry cupping therapy, Wet cupping therapy

Brief summary

This study aimed to compare the effectiveness of dry needling and cupping therapy in patients diagnosed with myofascial pain syndrome involving the trapezius, supraspinatus, infraspinatus, and levator scapulae muscles. Treatment efficacy was evaluated using the visual analog scale (VAS), the number of trigger points, the Likert satisfaction scale, and the multidimensional quality of life scale.

Detailed description

This study evaluated the effectiveness of dry needling (DN) and cupping therapy in 92 patients with chronic myofascial pain syndrome. Participants were randomly divided into two groups: one receiving a 10-session cupping regimen and the other undergoing a three-session dry needling protocol, with both groups performing home-based exercises. Results showed that both treatments significantly reduced pain and improved patient outcomes over three months. When compared directly, cupping therapy was more effective at reducing trigger points and improving overall quality of life. Conversely, dry needling resulted in higher levels of patient satisfaction. In conclusion, both methods are valuable tools for managing myofascial pain, and the choice of treatment may depend on whether the clinical priority is physical symptom relief or patient preference. Further research is recommended to better define the specific long-term applications of these therapies.

Interventions

In the tenth session, wet cupping was performed directly over the patients' TNs. In addition to the TNs, wet cupping was also applied at the Dazhui DU-14 point in all patients. Before initiating the procedure, the treatment area was disinfected with alcohol. Sterile single-use cups numbered 5 and 6 were applied to the treatment area. After 3 to 5 minutes, the cups were removed one at a time. After the area was cleaned, a No. 15 scalpel blade was used to make shallow vertical cuts at the cupping site. Afterward, the cups were returned to the same places. The procedure was performed three times without making any new cuts. The blood was drained, and the cups were put back on. The entire procedure lasted approximately 20 min. The cups were removed at the end of the procedure, and the area that had been treated was cleaned and covered properly.

PROCEDUREDry needling

Needling was performed while the TNs in the levator scapulae, supraspinatus, and upper part of the trapezius muscles were sitting. Patients were placed in the prone position for the middle and lower parts of the trapezius and infraspinatus muscles. To increase the accuracy of localization and minimize the risk of injury to nearby structures, needling was performed under ultrasound guidance. We used the Esaote MyLab 60 ultrasound machine that we have in our clinic for this. Standard single-use sterile acupuncture needles (0.25 mm × 25 mm) were used.

Sponsors

Turkish League Against Rheumatism
Lead SponsorOTHER
Atatürk University Scientific Research Projects Coordination Unit
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Back pain lasting more than three months * At least one palpable myofascial TN in the trapezius, supraspinatus, infraspinatus, and/or levator scapulae muscles * Written informed consent

Exclusion criteria

* Prior dry needling treatment * Prior cupping therapy * Severe cognitive dysfunction * Spinal fracture * Infection * Malignancy * Ankylosing spondylitis * Central nervous system injury * Psychiatric disorder * Diseases causing tissue degeneration * Conditions associated with spasticity or cerebrovascular disease * Cervical radiculopathy due to structural abnormalities * Muscle or tendon injuries of the shoulder or neck * Fibromyalgia or other conditions presenting with symptoms similar to myofascial pain syndrome * Use of anticoagulant or antiplatelet therapy * Thrombocytopenia or hemorrhagic disorders * A history of surgery or blood donation within the previous three months * Pregnancy * Breastfeeding * Presence of renal, hepatic, or severe cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Visual analog scaleFrom enrollment to the end of the first monthThe VAS score was used to measure pain intensity in each patient. Patients were told to rate their pain on a 10-cm horizontal line for the VAS test. A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
Trigger points countFrom enrollment to the end of the first monthTrigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
Multidimensional quality of life scoreFrom enrollment to the end of the first monthThe multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items. The overall score is obtained by summing the responses to all the items. Each item is given a score from 1 to 7, with a total score of 35 to 245. Higher scores indicate better functional status.
Likert satisfaction scaleFrom enrollment to the end of the first monthPatient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.

Secondary

MeasureTime frameDescription
Visual analog scaleFrom enrollment to the end of the third monthThe VAS score was used to measure pain intensity in each patient. Patients were told to rate their pain on a 10-cm horizontal line for the VAS test. A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
Trigger points countFrom enrollment to the end of the third monthTrigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
Multidimensional quality of life scoreFrom enrollment to the end of the third monthThe multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items. The overall score is obtained by summing the responses to all the items. Each item is given a score from 1 to 7, with a total score of 35 to 245. Higher scores indicate better functional status.
Likert satisfaction scaleFrom enrollment to the end of the third monthPatient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORFatih Baygutalp, Medical doctor

Department of Physical Medicine and Rehabilitation, Ataturk University Faculty of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026